Methyl prednisolone (Solu-medrol)
Methyl prednisolone
Pfizer Laboratories (Pty) Ltd
Registration
- Applicant
- Pfizer Laboratories (Pty) Ltd
- Registrations
- 2
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Solu-medrol 500 MG EACH VIAL CONTAINS METHYL PREDNISOLONE SODIUM SUCCINATE EQUIVALENT TO METHYL PREDNISOLONE 500 mg | 500 mg | L0025L/21.5.1/25 | Registered | Not determined | None |
| Solu-medrol 1000 MG EACH VIAL CONTAINS METHYL PREDNISOLONE SODIUM SUCCINATE EQUIVALENT TO METHYL PREDNISOLONE 1000 mg | 1000 mg | L0026L/21.5.1/26 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(8S,9S,10R,11S,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
Drag to rotate. Structure from PubChem CID 5755.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.